Therapeutic effects of eperisone on pulmonary fibrosis via
preferential suppression of fibroblast activity
Ken-ichiro Tanaka 1, *, Mikako
Shimoda 1, Toshifumi
Sugizaki 1, Maki
Ikeda 1, Ayaka
Takafuji 1, Masahiro
Kawahara 1, Naoki
Yamakawa 2, and Tohru
Mizushima 3.
1Laboratory of Bio-Analytical Chemistry, Research
Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino
University, 1-1-20 Shinmachi, Nishi-Tokyo 202-8585, Japan;2Shujitsu University School of Pharmacy, Okayama
703-8516, Japan; 3 LTT Bio-Pharma Co., Ltd, Shiodome
Building 3F, 1-2-20 Kaigan, Minato-ku, Tokyo 105-0022, Japan.